The JPL COVID-19 Response
NASA Ventilator Technology to be Featured in Upcoming Webinar
A new high-pressure ventilator developed by NASA engineers and tailored to treat coronavirus (COVID-19) patients today was approved by the Food and Drug Administration (FDA) for use under the FDA's March 24 ventilator Emergency Use Authorization.
Called VITAL (Ventilator Intervention Technology Accessible Locally), the device was developed by engineers at NASA's Jet Propulsion Laboratory (JPL) in Southern California to free up the nation's limited supply of traditional ventilators so they may be used on patients with the most severe COVID-19 symptoms.
"This FDA authorization is a key milestone in a process that exemplifies the best of what government can do in a time of crisis," said NASA Administrator Jim Bridenstine. "This ventilator is one of countless examples of how taxpayer investments in space exploration - the skills, expertise and knowledge collected over decades of pushing boundaries and achieving firsts for humanity - translate into advancements that improve life on Earth."
The Office of Technology Transfer and Corporate Partnerships at Caltech is offering a free license for VITAL and is reaching out to the commercial medical industry to find manufacturers for the device.
During the webinar, you will learn about the VITAL ventilator technology and how NASA’s technologies and capabilities are available to industry and other organizations through NASA’s Technology Transfer Program.